Psychedelics and ethics

Are you interested in exploring the ethical complexities surrounding the field of psychedelics? Join us for a thought-provoking webinar as we delve into real-world case scenarios, shedding light on the ethical dilemmas faced by professionals working in this evolving field.

Dr. Sandra Dreisbach and Dr. Lani Roy will guide participants through a range of ethics case studies, examining the intricate interplay of money, power, shadow, risk, and vulnerability within the realm of psychedelics. This webinar offers a unique opportunity to gain insights into the ethical considerations that arise in the context of psychedelic research, therapy, and integration.

Participants are encouraged to submit their own case studies and questions prior to the event. By sharing your experiences and concerns, you contribute to a vibrant discussion that aims to foster ethical awareness and best practices in the field. Please email your case studies and questions to alana@thesignsoflife.com.au. 

Rest assured, all information will be de-identified to ensure participant and community safety.

Throughout the webinar, we will address a variety of topics and ethical questions that emerge in the field of psychedelics:

• Ethics of working with organizations involved in psychedelic projects funded by entities known to violate codes of ethics and engage in illegal behaviour. Is it acceptable to collaborate under such circumstances?
• Ethical considerations when referring individuals to the underground psychedelic community as a last resort for those who have exhausted conventional treatment options and cannot afford overseas alternatives.
• Effective integration of insights and transformative experiences induced by psychedelics into patients' long-term mental health journeys.
• What support systems are needed to help individuals navigate the integration process and sustain the positive changes they experience after psychedelic therapy?
• Balancing the potential therapeutic benefits of psychedelics with associated risks and potential adverse effects. Exploring protocols and safeguards to minimize harm and ensure patient well-being during psychedelic therapies.
• Respectful and ethical incorporation of traditional plant medicines and indigenous healing practices into contemporary psychedelic-assisted psychotherapy. Ensuring the involvement, respect, and fair compensation of indigenous communities for their knowledge and contributions.

This webinar invites professionals, researchers, therapists, and individuals interested in the ethical landscape of psychedelics to engage in a critical dialogue that aims to shape responsible and sustainable practices in this emerging field. Don't miss this opportunity to expand your understanding and contribute to the ethical development of the psychedelic community.

Dr. Sandra Dreisbach

Ethicist and Psychedelic Ethics Specialist with a MA, PhD in Philosophy exploring ethical decision-making and moral psychology 

Sandra is an Ethics Advisor active in Psychedelic Integration, Therapy, Education and Advocacy as well as a Psychedelic facilitator, cofounder of EPIC (Ethical Psychedelic International Community) and DecrimFirst collaborative communities as well as the leader of the Santa Cruz Psychedelic Society. Sandra has been teaching Bioethics at the University of California, Santa Cruz for the Biomolecular Engineering and Philosophy Departments for the past ten years, worked for many years in the tech industry primarily at Apple, and is a Reiki Master in multiple lineages. Sandra focuses on listening and uplifting the voices and values of the Psychedelic Community especially the disenfranchised with the heart space intention of compassion and love.

Dr. Alana Roy 

Founder/ Director of the Signs of Life Psychology 

Dr. Alana (Lani) Roy is a dedicated and accomplished professional in the field of psychology, social work, and advocacy. As the Founder and Director of The Signs of Life Psychology, Lani has been actively involved in mental health, suicide prevention, trauma, sexual abuse, family violence, and the disability sector for over 15 years.
Lani's expertise encompasses a wide range of areas, including borderline personality and dissociative identity disorder. She has worked extensively in community settings, supporting victims of ritual abuse, childhood and adult sexual assault, women in the sex industry, and survivors of human trafficking. Lani specialises in complex trauma, disabilities, and dual diagnosis, and she is known for her commitment to providing therapy in Auslan sign language to the Deaf community.
With a focus on harm reduction and evidence-based therapies, Lani has been at the forefront of the emerging field of psychedelics. She is an Associate Research Fellow for Swinburne University and a Founding Board Member of the Australian Multidisciplinary Association for Psychedelic Practitioners (AMAPP). Lani collaborates closely with key advisors and researchers to ensure public and professional safety in this rapidly evolving field.